Increasing evidence implicates A␤ peptides self-assembly and fibril formation as crucial events in the pathogenesis of Alzheimer disease. Thus, inhibiting A␤ aggregation, among others, has emerged as a potential therapeutic intervention for this disorder. Herein, we employed 3-aminopyrazole as a key fragment in our design of non-dye compounds capable of interacting with A␤42 via a donor-acceptor-donor hydrogen bond pattern complementary to that of the ␤-sheet conformation of A␤42. The initial design of the compounds was based on connecting two 3-aminopyrazole moieties via a linker to identify suitable scaffold molecules. Additional aryl substitutions on the two 3-aminopyrazole moieties were also explored to enhance stacking/hydrophobic interactions with amino acids of A␤42. The efficacy of these compounds on inhibiting A␤ fibril formation and toxicity in vitro was assessed using a combination of biophysical techniques and viability assays. Using structure activity relationship data from the in vitro assays, we identified compounds capable of preventing pathological self-assembly of A␤42 leading to decreased cell toxicity.
Alzheimer disease (AD) 2 is the most common age-related neurodegenerative disorder affecting nearly 25 million patients (1) . It is characterized by progressive cognitive decline and eventually a debilitating dementia (2) . Currently available pharmacologic interventions are limited to compounds enhancing cholinergic function (acetylcholinesterase inhibitors) or acting as N-methyl-D-aspartic acid receptor antagonist, but these drugs only provide symptomatic relief without halting the progression of the disease (3) (4) (5) . Thus, there is an enormous medical need for novel disease-modifying therapies that target the underlying neuropathological mechanisms involved in the development of AD.
The two pathological hallmarks of AD are senile amyloid-␤ (A␤) plaques (6) and neurofibrillary tangles made of aggregated Tau (7) . According to the amyloid cascade hypothesis, the aggregation of A␤ is the primary cause of the disease (8 -11) . Thus, removal of toxic amyloid deposits is a central therapeutic aim in AD (12) . The A␤1-42 peptide (A␤42) is the more neurotoxic form of A␤, as A␤42 has more pronounced oligomerization and aggregation properties (13) (14) (15) .
The majority of studies on A␤ toxicity suggest that low molecular weight soluble oligomers or high molecular weight prefibrillar intermediates account for its neurotoxicity (16 -20) , synapse loss, and cognitive impairment (21) . A␤ fibrils and high molecular weight oligomers are rich in ␤-sheet structures, whereas low molecular weight oligomers (dimers, trimers, tetramers) do not adopt stable secondary structures. The different transient A␤ species most likely exist in equilibrium with each other (22) (23) .
The amyloid cascade hypothesis offers several strategies for therapeutic intervention, including inhibition of A␤ production (␤and/or ␥-secretase inhibitors) or inhibition of A␤ aggregation and toxicity. Preventing A␤ aggregation is therapeutically attractive because this might be an exclusively pathological process and would not interfere with the physiological function of the amyloid precursor protein (20) .
Thus, a potential method of treating AD is to administer small molecules capable of preventing A␤ oligomerization, fibrillization, and/or plaque formation (24 -26) . The majority of non-peptidic anti A␤-aggregation inhibitors identified by in vitro screening are metal chelators (27) , dyes (28, 29) , and polyphenolic natural products (30 -34) .
An alternative approach is based on a rational design utilizing acylated 3-aminopyrazoles with a donor-acceptor-donor hydrogen bond pattern complementary to that of the ␤-sheet of A␤42 (35, 36) (Fig. 1A) . These compounds bearing 3-aminopyrazoles are either dimeric compounds, where the 3-aminopyrazole moieties are connected by a rigid oxalyl-linker, or oligomeric compounds, where the 3-aminopyrazole moieties are directly linked to each other by amide bonds (35, 36) .
Highly ordered -stacking interactions between aromatic ring systems play important roles in ␤-sheet formation and assembly of complex biological and chemical supramolecular structures (37) . Previous studies suggested that the anti-aggregation properties of polyphenols result from their ability to interfere with -stacking interactions between aromatic side chains in amyloid (38) . Thus, we hypothesized that in addition to the already existing donor-acceptor-donor contacts, aromatic substituents attached at the 4-or 5-position of the 3-aminopyrazole ring should increase the anti-aggregation potency of our compounds. Herein, we demonstrate that rationally designed small molecules inhibit A␤ oligomerization, fibril formation, and protect against A␤-induced toxicity.
EXPERIMENTAL PROCEDURES
Compound Synthesis-The synthesis of compounds 1-14 ( Thioflavin T (ThT) Fluorescence Assays-A␤42 lyophilized powder (Bachem) was reconstituted in hexafluoroisopropanol to 1 mM. The peptide solution was sonicated for 15 min at room temperature and agitated overnight, and aliquots were made into non-siliconized microcentrifuge tubes. The hexafluoroisopropanol was then evaporated under a stream of argon. The resulting peptide film was dried under a vacuum for 10 min, tightly sealed, and stored at Ϫ80°C until used.
For the ThT assay, a PBS solution in non-siliconized incubation tubes was prepared with final concentrations of 330 M inhibitors, 33 M A␤42, and 10 M ThT (Sigma). The final concentration of DMSO was 12.8%. Therefore, the final molar ratio of test compound to A␤42 was 10:1. A solution containing A␤42 and 10 M ThT only was used to measure the maximal relative fluorescence unit (defined as 100% relative fluorescence units). A negative control without A␤42 defined as 0% relative fluorescence unit was also prepared for each compound to exclude compound-derived fluorescence. The assay was run for 24 h at 37°C, and the spectrofluorescence (excitation, 440 nm; emission, 485 nm) was read in 6 replicates in black 384-well assay plates (PerkinElmer Life Sciences) in a microplate reader (Tecan). The ThT-assay IC 50 determination was performed as described above with the exception that the following 7 concentrations of test compound were used: 330, 82.5, 20.63, 5.16, 1.29, 0.32, and 0.08 M. The IC 50 values were determined from the percent inhibition of aggregation values obtained at the end of the measurement. Thereafter these values were plotted against the log of the inhibitor concentration. By fitting the data with a sigmoidal function in the Prism software (GraphPad Software), the IC 50 values were obtained.
A␤42 protofibrils were prepared essentially as described (20, 39) . Briefly, 1 mg of lyophilized A␤42 was solubilized in 50 l of 100% anhydrous DMSO in a 1.5-ml sterile microtube. Then, 800 l of high purity water was immediately added, and the pH of the resulting solution was adjusted to ϳ7.6 by adding 10 l of 2 M Tris-base, pH 7.6. The solution was centrifuged (16,000 ϫ g; 4°C; 10 min), and the supernatant was injected into a Superdex 75 column previously equilibrated with 50 ml of 10 mM Tris-HCl, pH 7.4. A␤42 monomers were prepared as described above, except that 1 mg of lyophilized A␤42 was solubilized in 6 M guanidine hydrochloride (1 ml), and the solution was directly injected into the Superdex 75 column (20, 39) . A␤42 was eluted at a flow rate of 0.5 ml/min, and 1-ml fractions were collected in 1.5-ml sterile microtubes (supplemental Fig. S10 ). The elution was monitored at UV absorbance A 210 , A 254 , and A 280 . A␤42 concentration was determined from the A 280 using the theoretical molar extinction coefficient 1490 M Ϫ1 cm Ϫ1 (39, 40) . In Jan et al. (39) we validated the reliability of this method.
A␤42 monomers and protofibrils (20 M) were separately co-incubated with the test compounds at the following molar ratios (A␤42 test compounds): 1:0.5, 1:1, and 1:2 in 1.5-ml sterile microtubes (500 l/tube, in duplicates). For this purpose, dilutions of the test compounds were prepared from stock solutions in 100% anhydrous DMSO in such a manner that each tube containing A␤42 monomers or protofibrils received an identical volume of the test compound stock solutions. As controls, the equal volume of 100% anhydrous DMSO was separately added to A␤42 monomers and protofibrils. For validation experiments, purified A␤42 monomers and protofibrils were co-incubated with selected test compounds at a molar ratio of 1:4 (10 M A␤42, 40 M compound).
The samples were incubated at 37°C, and fibril formation was monitored by the ThT binding assay and transmission electron microscopy (TEM). ThT fluorescence was determined every 24 h up to 72 h of incubation. For this purpose, 80 l of A␤42 monomers or protofibrils with and without test compounds were mixed with 20 l of ThT (100 M) and 10 l of glycine-NaOH, pH 8.5 (500 mM), in a Nunc 384-well fluorescence plate (100 l/well). ThT fluorescence of each sample was measured in an Analyst AD fluorometer (Molecular Devices) at excitation and emission wavelengths of 450 and 485 nm, respectively.
A␤42 fibrils were prepared as described (20, 39) . Briefly, a concentrated solution (1 mg/ml) of the A␤42 preparation to obtain protofibrils, containing monomers, protofibrils, and a small amount of fibrils, was incubated at 37°C, pH 7.8, under mild agitation for 48 h. A␤42 fibrils (100 M) were incubated at 37°C with either DMSO (40 M) or the test compounds (40 M) in 1.5-ml sterile microtubes (600 l/tube, in duplicates), and fibril disaggregation was monitored by the ThT binding assay and TEM. ThT fluorescence was determined at 0 and 48 h before adding the test compounds to monitor A␤42 fibril formation. After the addition of DMSO or the test compounds, ThT fluorescence was determined at 24 and 48 h.
Analysis of Soluble A␤42 by SDS-PAGE-After 48 h of incubation at 37°C, A␤42 samples (monomers or protofibrils) with or without test compounds were centrifuged (16,000 ϫ g, 15 min, 4°C). In contrast, A␤42 fibril samples with or without test compounds were ultracentrifuged (100,000 ϫ g, 30 min, 4°C). Then, 10 -12 l of the supernatant (monomers or protofibrils or fibrils) was mixed with SDS loading buffer (41) and subjected to electrophoresis on NuPAGE 4 -12% Bis-tris SDS gels (Invitrogen). The supernatant from A␤42 fibrils was also filtered through 0.22-m filters previously equilibrated with 10 mM Tris-HCl, pH 7.4, by centrifugation (14,000 rpm, 10 min). The protein bands were visualized by silver staining using a commercial kit (Invitrogen).
TEM-A 5-10-l droplet of sample containing A␤42 was deposited on a 200-mesh Formvar-coated TEM grid (EM Sciences) and allowed to settle for 60 s. Then the excess solution was wicked away by gently applying a piece of blotting paper to the edge of the grid. Then a 10-l droplet of 2% uranyl acetate was deposited on the grid and allowed to settle for 60 s. The excess solution was removed as above. Then the grid was vacuum-dried by gently applying the vacuum probe on a grid side. Image acquisition was carried out using a Phillips CM10 microscope operated at an acceleration voltage of 80 kV.
Fluorescence Correlation Spectroscopy (FCS)-Measurements were performed using a ConfoCor I (Zeiss, Evotec) instrument equipped with an argon ion laser. The pinhole diameter was 40 m. The instrument was calibrated with the dye rhodamine 6G with a known diffusion coefficient in water at 20°C of 2.8⅐10 Ϫ6 cm 2 /s. The A␤42 peptide was labeled N-terminally with the fluorescence dye Oregon green as described (36) . Compounds were tested using preformed aggregates that were prepared freshly by diluting low concentrated (500 nM) DMSO-stock solutions of Oregon green-labeled A␤42 1:1 with deionized water. For each measurement a new aliquot, stored at Ϫ70°C, was thawed and sterile-filtered through a nylon filter (0.2 m) to remove large aggregates. Final concentration of Oregon green-labeled A␤42 peptide in the assay was 5 nM in PBS and 6% DMSO.
The compounds were dissolved in 100% anhydrous DMSO at 50-fold concentration of the desired assay concentration, so that a constant amount of 1 l of ligand stock solution was always added to the test solution. This latter contained 10-fold concentrated PBS, water, 8 M mercapto-ethylamine and was distributed as 48-l aliquots to 12 standard reaction vials. Mercaptoethylamine was added to the assay mixtures to reduce the rather high triplett fraction of the dye Oregon green as a so called triplett quencher (42) .
After the calibration of the FCS instrument, the assay was started by adding 1 l of A␤42-Oregon green-labeled peptide in DMSO, and the aggregation process was analyzed over a period of 5 h. Samples were prepared at least as duplicates. Data eval-uation was carried out by averaging the fluorescence fluctuations for every well and counting data points that deviated more than 5-fold from the mean fluorescence signal, i.e. every peak at a Z-score equal or higher than ϩ5 was counted as an A␤42 aggregate (36) . Because the intensity of the fluorescence peaks is related to the number of dye molecules present in A␤42 aggregates, not only the number of peaks but also the product of number and height of peaks was evaluated. The results of every measurement were normalized to the values measured for the control samples (36) .
Cell Viability Assay-To evaluate cell viability of SH-SY5Y neuroblastoma cells, a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay was employed according to the manufacturer's instructions (Promega). Crude A␤42 was prepared as described previously (20, 39) . Briefly, 1 mg of lyophilized A␤42 was solubilized in 20 l of 100% anhydrous DMSO in a 1.5-ml sterile microtube. Then 800 l of high purity water was immediately added, and the pH of the resulting solution was adjusted to ϳ7.6 by adding 10 l of 2 M Tris base, pH 7.6. The solution was always freshly prepared and used immediately. Crude A␤42 with or without compound was incubated for 30 min in serum-free culture medium complemented with insulin and then added onto the cells (plated in 96-wellplates) for 24 h. The MTT-dye solution was added for the last 3 h of incubation. Then the cells were incubated for 1 h in a solubilization solution, and the blue formazan product was measured at 570 nm using 690 nm as a reference wavelength in a microplate reader (Tecan). The signal was expressed as percentage of the A 570 -690 count from the vehicle-treated cells.
Internalization Assay-To evaluate the internalization of crude A␤42, SH-SY5Y cells were plated in 6-well plates at a density of 5 ϫ 10 5 cells/well. Crude A␤42 (3 M) was preincubated for 1 h with compound (3 M) in a 1:1 molar ratio. The SH-SY5Y cells were then incubated for 2 h with the crude A␤42/compound mixture, washed with ice-cold PBS, trypsinized, and centrifuged in ice-cold PBS at 1500 rpm for 5 min. The cells were resuspended in 80 l of cell lysis buffer (Cell Signaling Technology) for 5 min on ice and then briefly sonicated. The lysate was centrifuged for 5 min at 14,000 ϫ g, and the protein concentration of supernatants was determined using a microbicinchoninic acid protein assay kit (Thermo Scientific). Internalized A␤42 was detected with a human A␤42 ELISA high sensitivity detection kit (Millipore) following the manufacturer instructions, and the data were normalized by the total protein concentration of the samples.
Nuclear Magnetic Resonance Experiments-One-dimensional and two-dimensional NMR experiments were performed at 5°C on a 700-MHz spectrometer (Bruker) equipped with a cryogenic probe. Commercially available 15 N-labeled A␤42 (rPeptide) was solubilized in 100 mM NaOH at a concentration of 2 mg/ml. Compounds were dissolved in deuterated DMSO at 100 mM concentration. In the titration experiments the initial sample contained 50 M 15 N-labeled A␤42 in 50 mM phosphate buffer (pH 7.5, adjusted after the addition of the labeled peptide and kept constant along the titration). The titration series contained compounds 6, 7, or 10 in increasing compound/peptide ratios up to a ratio of ϳ30. At this ratio, the DMSO concentration was ϳ1.4% (v/v). The reference experiment was conducted using DMSO at 1.4% concentration and the same pH but without any added compound. Chemical shift referencing and intensity normalization was performed on the basis of an internal 4,4-dimethyl-4-silapentane-1-sulfonic acid reference.
Saturation transfer difference (STD) experiments were conducted at the specified irradiation frequencies, with irradiation at 60 ppm used as the reference spectrum. The difference between the saturated and reference spectra (saturated-reference) is shown as the STD spectra. A saturation block of 5 s and a recycle delay of 7 s were used for STD experiments. The samples contained 0.4 mM compound with or without the added peptide (at compound/peptide ratio of 16:1). The sample without the added peptide did not show any STD effect at the used frequencies. Two preparations of A␤42 were used for the STD experiments; the first was the normally solubilized A␤42 supposed to be rich of the monomeric A␤42 peptide, and the second was incubated at 37°C for 24 h (without stirring) to be enriched in oligomeric species.
RESULTS

Screening for Inhibitors of Fibril Formation Using ThT
Assays-We first investigated the effect of our compounds (Fig.  1B) on the aggregation and fibril formation of A␤42 by the mean of different ThT fluorescent assays (43) . Because this dye binds to amyloidogenic cross-␤-sheet structures, ThT assays are widely used for the identification and quantification of amyloid fibrils and to monitor fibril formation kinetics (44) . For this purpose a high concentration of ThT was added to A␤42 fibrillization samples in order to be in excess compared with the number of potential ThT-fibril binding sites (44) .
A␤42 was prepared for the first screening assay as a resuspended peptide film containing monomeric and heterogenic mixtures of low molecular weight A␤42 oligomers (Ͻ16 kDa), as determined by Western blot and centrifugation ( Fig. 2A) . We have shown that such crude A␤42 preparations are toxic to cells (20) . The incubation time was 24 h, as preliminary experiments have shown that within this time the aggregation process was completed (ThT signal reached a steady state). In general, a compound was considered active in this assay when at least 70% inhi- Attaching bulky aromatic substituents at the 4-position of 3-aminopyrazole as for compound 1 (Fig. 1B ) did not yield an active compound ( Fig. 2A ). This may be due to the fact that the rigid (-C(O)C(O)-) linker prevented additional interactions of the aromatic substituents with A␤42. The incorporation of a more flexible (-CH 2 CH 2 -) linker in compound 2 increased its activity compared with 1. However, the inhibition of A␤42 aggregation was still Ͻ70%, indicating that compounds with substituents at the 4-position of 3-aminopyrazole were suboptimal.
By employing a flexible (-CH 2 CH 2 -) linker and attaching aromatic substituents at the 5-position of the 3-aminopyrazole ring compounds 3-8, 10, and 13 (Fig. 1B) were obtained. Compounds having strong electron-donating groups (p-OCH 3 for compound 4 or p-N(CH 3 ) 2 for compound 7), weak electrondonating groups (p-CH 3 for compound 3 or p-phenyl for compound 8), or strong electron-withdrawing groups (p-Cl for compound 5 or p-F for compound 6) attached to the 5-phenylsubstituents, all displayed Ͼ70% of inhibition of A␤42 aggregation in this assay ( Fig. 2A ). These data, however, showed no clear preference for the different phenyl substituents at the 5-position of 3-aminopyrazole. Furthermore, compounds 10 and 13 with a non-symmetrical substitution pattern at the 5-position of the 3-aminopyrazole moiety displayed equal activity. Thus, the heteroaromatic 2-thienyl moiety in compound 10 retained the inhibition of fibrillization activity. However, compound 9 bearing a heteroaromatic 2-furanyl moiety displayed a decrease in activity with Ͻ70% inhibition of A␤42 aggregation. Compound 13 containing the flexible (-CH 2 CH 2 -) linker showed superior inhibition of A␤42 aggregation when compared with the structurally related compounds 11 and 12 containing a partially reduced (-C(O)CH 2 -) linker. Compound 14 containing a shorter (-CH 2 -) linker was inferior to the otherwise identical compound 3 having a (-CH 2 CH 2 -) linker. However, the shorter but more flexible (-CH 2 -) linker was superior to the partially reduced (-C(O)CH 2 -) linker (compare compounds 11, 12, and 14; Fig. 2A ). In summary, compounds containing a flexible (-CH 2 CH 2 -) linker unit and having an aromatic substituent attached to the 5-position of 3-aminopyrazole ( Fig. 1B ) demonstrated the strongest inhibition of A␤42 fibrillization.
Investigating the Inhibition of Fibril Formation Using Purified A␤42 Monomers and Protofibrils-To elucidate which A␤42 species interact with our compounds and also to confirm the screening results obtained with the A␤42 peptide film, we next investigated the potency of compounds 1-14 on inhibiting fibril formation of purified A␤42 monomers or protofibrils, i.e. interference with A␤42 nucleation or elongation. For this purpose A␤42 monomers or A␤42 protofibrils of defined size were prepared by size exclusion chromatography (supplemental Fig.  S10 ) and characterized as previously described (39) .
Testing the compounds by incubating them with A␤42 monomers or protofibrils (A␤42:compound molar ratios of 0.5, 1, and 2; 72-h incubation time) revealed that compounds 3-7, 10, and 13 led to a Ն50% inhibition of fibril maturation starting from A␤42 monomers (Fig. 2B) , and a A␤42:compound ratio of 1:2 inhibited the elongation of A␤42 protofibrils into mature fibrils (Fig. 2C ). At substoichiometric concentrations (0.5 molar ratio), the inhibition of fibril formation was generally weaker for most of the compounds tested (Fig. 2, B and C) .
In contrast, compounds 1, 2, 8, 9, 11, 12, and 14 exhibited low to moderate activity, i.e. Յ50% against the fibrillization of A␤42 monomers ( Fig. 2B ) or protofibrils ( Fig. 2C ). Interestingly, compound 1 appeared to enhance the fibrillization of monomeric A␤42 when compared with the control. The data showed that compounds 1 and 2 with an aromatic moiety at the 4-position of the 3-aminopyrazole moiety were less effective in inhibiting the fibrillization of both A␤42 monomers and protofibrils when compared with compounds 3-7, 10, and 13 having an aromatic moiety at the 5-position of the 3-aminopyrazole. Unlike the results obtained with the A␤42 peptide film, compounds 11 and 12 showed similar inhibition of A␤42 fibril formation starting from both A␤42 monomers and protofibrils. Again, compound 9, having the 2-furanyl moiety, displayed a weaker effect on inhibition of fibril formation (Ͻ50%) in both assays. In contrast to the results obtained with the crude A␤42 peptide film, compound 8 was less potent when A␤42 monomers or protofibrils were used, displaying Ͻ50% inhibition of A␤42 fibril formation.
Taken together, the results from our in vitro screening assays (Fig. 2, A-C) were in good agreement. Thus, compounds 3, 5, 6, 7, 10, and 13 containing a flexible (-CH 2 CH 2 -) linker and different aromatic substituents at the 5-position of 3-aminopyrazole displayed potent inhibition of both A␤42 nucleation and A␤42 protofibril elongation.
Validation of Representative Hit Compounds and Elucidation of Their Mode of Action-Compound 1 was selected as a negative control because it did not show any activity in the previous in vitro screening assays. In contrast, compounds 5, 6, 7, and 10 displayed good inhibition of A␤42 aggregation in the previous screening assays. These compounds were again tested in the ThT assay using the A␤42 peptide film preparation to determine their IC 50 values. For compound 1 the IC 50 could not be determined (data not shown). The IC 50 values for compounds 5, 6, 7, and 10 were 8.6, 40.5, 7.5, and 29 M, respectively ( Fig. 3 and supplemental Fig. S1 ). In summary, compound 7 displayed the most potent inhibition of A␤42 fibrillization in the ThT assay followed by compounds 5, 10, and 6.
To explore in more details the mechanism(s) by which compounds 1, 5, 6, 7, and 10 inhibited the fibrillization of A␤42, we investigated their effect on the kinetic of A␤42 fibril formation starting with purified A␤42 monomer preparations. Fibril formation kinetic of A␤42 monomers was studied over a period of 48 h with and without compounds (Fig. 4A ) using a ThT readout (45) . Incubation of A␤42 monomers in the presence of compounds 5, 6, 7, and 10 resulted in an initial rise of the ThT signal after 24 h similar to A␤42 monomers incubated without compounds. However, after 48 h the ThT signal was significantly lower as compared with the control (Fig. 4A ). Compound 1 had no effect on A␤42 monomer fibrillization as the increase in ThT signal over 48 h was comparable to the DMSO control.
Testing compounds in a fluorescent-based assay has an inherent risk of readout artifacts. As an example, compounds with absorption at ϳ440 nm (the excitation wavelength of ThT) may quench or interfere with the fluorescence readout (44, 46) . So, we employed an orthogonal, non-fluorescence-based assay based on the different sedimentation properties of soluble and aggregated A␤42. For this, samples were centrifuged, and supernatants were analyzed for soluble A␤42 protein (monomers, oligomers, and protofibrils) by SDS-PAGE (Fig. 4B ). In agreement with the ThT data, SDS-PAGE analysis after 48 h of incubation at 37°C revealed a substantial reduction in the content of soluble A␤42 in the control and compound 1-treated sample, suggesting that almost all soluble A␤42 was converted into insoluble fibrils. This was also in agreement with the TEM images (Fig. 4C ) of the control and compound 1-treated sample showing bundles of extensive mature fibrils.
The samples treated with compounds 5, 6, 7, and 10 showed that significant amounts of soluble A␤42 (monomers and protofibrils) remained in the supernatant, which was also in agreement with the ThT data. This suggests an interaction of compounds 5, 6, 7, and 10 with A␤42 oligomers/protofibrils and subsequent prevention of their maturation into insoluble species. In agreement with the ThT and SDS-PAGE data, samples containing compounds 5, 6, 7, and 10 did not show mature fibrils in TEM but resulted in the formation of non-fibrillar clusters of curvilinear protofibrils (Fig. 4C ). The curvilinear, irregular morphology of A␤42 protofibrils is quite different from mature amyloid fibrils (47, 48) .
Thus, compounds 5, 6, 7, and 10 did not sequester A␤42 monomers and, hence, did not interfere with A␤42 monomer oligomerization and seed formation. Instead, compounds 5, 6, 7, and 10 appeared to target prefibrillar A␤42 oligomers to prevent fibrillization.
Next, we performed a kinetic analysis of the fibrillization of preformed A␤42 protofibrils to probe the ability of compounds 1, 5, 6, 7, and 10 to interact with these structures. In the presence of DMSO alone, A␤42 protofibrils displayed a ThT signal already at 0 h, confirming the presence of oligomeric aggregates with high ␤-sheet content (Fig. 5A) . Then, over the first 24 h, the ThT fluorescence increased with time, consistent with the conversion of protofibrils into mature fibrils. The fibrillization process then slowed down over the next 24 h of incubation because the conversion of protofibrils into mature fibrils requires the presence of small, soluble A␤42 species. The rise of the ThT signal for samples treated with compound 1 suggested a somehow promoted A␤42 protofibril fibrillization process (Fig. 5A ). This is in agreement with the TEM image (Fig. 5C) where the control and compound 1 sample displayed elongated fibrils among clusters of protofibrils.
In contrast, compounds 5, 6, 7, and 10 appeared to interact readily with A␤42 protofibrils as evident by the significant decrease in ThT signal after adding the compounds to A␤42 protofibrils at 0 h. The TEM images of samples containing compounds 5, 6, 7, and 10 were in agreement with the ThT data as they showed clusters of elongated curvilinear protofibrils (Fig.  5C ). Thus, compounds 5, 6, 7, and 10 did not interfere with the oligomerization of A␤42 protofibrils but blocked their fibrillization.
SDS-PAGE analysis was performed to quantify the remaining amount of soluble A␤42 species (monomers, oligomers, and protofibrils). The A␤42 protofibrils generated with our protocol were SDS-sensitive, and a band similar to monomeric A␤42 was detected at 0 h of incubation (Fig. 5B) . A significant decrease in the amount of soluble A␤42 was observed after 48 h of incubation for samples containing compounds 1, 5, 6, and 10. Thus, in agreement with the TEM images, compounds 5, 6, and 10 were not able to disaggregate A␤42 protofibrils. Interestingly, a larger amount of soluble A␤42 was detected for samples containing compound 7 or the control after 48 h of incubation ( Fig. 5B) as evident by the A␤42 band intensity.
Thus, the most plausible mechanism of action for compounds 5, 6, 7, and 10 is an interaction with A␤42 protofibrils that results in the formation of clusters of elongated curvilinear protofibrils with low ␤-sheet content. In addition, compound 7 caused the formation of soluble A␤42 aggregates similar to SDS-sensitive A␤42 protofibrils.
To test the ability of compounds 6, 7, and 10 to disaggregate amyloid fibrils, they were incubated with preformed mature A␤42 fibrils, and the disaggregation was monitored by SDS-PAGE, TEM, and ThT fluorescence (Fig. 6 ). The crude A␤42 preparation already displayed a strong ThT signal at 0 h that increased considerably over the next 48 h of A␤42 fibril maturation (Fig. 6D ). The addition of DMSO resulted in a slight decrease of the ThT signal after 24 of incubation, suggesting a minor interference with the ThT fluorescence. However, the increase of the ThT signal after 48 h of incubation suggested that DMSO did not interfere with the reassociation of mature fibrils. In contrast, samples containing compounds 6, 7, and 10 showed a significant decrease of the ThT signal after 24 and 48 h of incubation, indicating a dissociation of preformed A␤42 fibrils. The ThT signal for samples containing compounds 6 and 10 after 24 and 48 h of incubation was similar to the initial crude A␤42 preparation. In contrast, the ThT signal for samples containing compound 7 after 24 and 48 h of incubation was reduced when compared with the initial crude A␤42 preparation ( Fig. 6D) .
To verify any disaggregation of mature fibrils by DMSO and compounds 6, 7, and 10, the amount of soluble A␤42 species (monomers, oligomers, and protofibrils) after 24 and 48 h of incubation was determined by SDS-PAGE analysis of the supernatant (Fig. 6A) . Overall, the amount of soluble A␤42 was not significantly different between the preformed A␤42 fibrils and the samples treated with DMSO or compounds 6, 7, and 10, suggesting that there was no disaggregation of preformed A␤42 fibrils. To determine the amount of A␤42 monomers, the supernatant was additionally filtered and analyzed by SDS-PAGE (Fig. 6B) . In general, the A␤42 monomer bands were much weaker in intensity than the corresponding soluble A␤42 bands (compare Fig. 6, A and B) , suggesting that the majority of soluble A␤42 species were oligomers and protofibrils. Neither DMSO nor compounds 6, 7, and 10 increased the amount of monomeric A␤42, confirming that compounds 6, 7, and 10 did not disaggregate preformed A␤42 fibrils. These findings were in agreement with the TEM images, where the DMSO sample as well as the samples treated with compounds 6, 7, and 10 after 48 h of incubation displayed networks of fibrils (Fig. 6C) .
Thus, the most plausible mechanism of action for compounds 6, 7, and 10 is an interaction with A␤42 fibrils that did not lead to their disaggregation. In addition, compound 7 caused the formation of A␤42 fibrils with lower ␤-sheet content. 5, 6, 7 , and 10 by FCS-Another ThT-independent method for the assessment of inhibition of A␤42 aggregation properties of small molecules is FCS. FCS allows the determination of the diffusion time of a fluorescent molecule through a small volume, i.e. the confocal volume of a laser beam of about one femtoliter. Protein aggregation causes slower diffusion times, and highly labeled large aggregates cause large fluorescence bursts when they pass through the focus (36) .
Investigating the Inhibition Mechanism of Compounds
In the case of self-associating molecules, aggregation can be characterized by the number of fluorescence bursts (Fig. 7A) or by the product of number and intensity of fluorescence bursts (Fig. 7B) . Unlike ThT-based methods that require the presence of cross-␤-sheet structures in the protein aggregates to give rise to a signal, FCS detects any aggregates containing a fluorescent molecule passing through the detection volume. Very large aggregates, however, will not be detected as they will deposit below the confocal volume.
Compounds 5, 6, and 7 reduced the number of small A␤42 aggregates passing the laser beam by ϳ50% when compared with conditions with DMSO alone. In contrast, compound 10 did not reduce the number of small A␤42 aggregates (Fig. 7A) . Taking into account not only the number of A␤42 aggregates but also their size (product of peak number and intensity), it was revealed that compounds 6 and 7 were more potent than compound 5 in both reducing the number of A␤42 aggregates as well as their size (Fig. 7B) . Overall, compound 6 was most efficient in inhibiting A␤42 aggregation monitored by FCS (Fig.  7, A and B) .
Investigating the Interaction of Compounds 6, 7, and 10 with A␤42 by Nuclear Magnetic Resonance Spectroscopy-NMR spectroscopy was used to follow the effects of compounds 6, 7, and 10 on A␤42. As revealed by the intensity of 1 H signals in one-dimensional NMR spectra, the addition of compound 6 resulted in a considerable loss of signal intensity. The NMR signal intensity loss showed a clear dependence on the concentration of the compound, resulting in a decrease of up to ϳ30% at a compound/A␤42 ratio of ϳ30:1 (Fig. 8) . The decrease in intensity was due to the presence of the compound, as the addition of a reference solution (pure DMSO) did not cause any significant changes in NMR signal intensities. Very similar changes in NMR spectra were also observed for compounds 7 (supplemental Fig. S2A ) and 10 (supplemental Fig. S2B) . Taken together the observed changes suggest that compounds 6, 7, and 10 induce formation of large A␤42 oligomers that are broadened beyond the detection limit of liquid-state NMR due to slow tumbling. In addition, separate analysis of backbone and side chain signals of A␤42 in the presence of compound 7 showed that the intensity decrease of the methyl groups is slower, indicating that they remain partially mobile in the oligomeric state (supplemental Fig. S2A ). In contrast, almost identical signal decays for methyl and amide signals were observed for compounds 6 (Fig. 8) and 10 (supplemental Fig. S2B ). Thus, in case of compounds 6 and 10, the formed A␤42 oligomers had either less flexible side chains or had a larger molecular weight.
To obtain residue-specific information about the interaction of compounds 6, 7, and 10 with A␤42, two-dimensional [ 1 H, 15 N]heteronuclear single quantum coherence spectra (49) of A␤42 were measured in the absence and presence of the compounds. The variation of chemical shifts of amide 1 H and 15 N spins of A␤42 upon the addition of the compounds represented alterations in their chemical environment after direct binding and/or induced conformational changes. In addition, the intensity of 1 H, 15 N correlation peaks was affected by the exchange between the free and bound forms of the peptide and their intrinsic transverse relaxation rates. Therefore, a combined monitoring of chemical shifts and peak intensities can provide insights into the thermodynamic and kinetic aspects of the binding of small molecules to proteins (50) . In line with the observation from one-dimensional 1 H NMR spectra, the addition of compounds 6, 7, and 10 resulted in a decrease in the intensity of [ 1 H, 15 N] correlation peaks (supplemental Fig. S3 ). The intensity decrease was quite uniform along the sequence with the exception of residues 25-29, in particular for compounds 7 (supplemental Fig. S3B ) and 10 (supplemental Fig.  S3C ).
Besides the intensity decrease, a slight perturbation of backbone amide chemical shifts was observed (Fig. 9A ). In case of compounds 7 and 10, it was similar both in magnitude and profile to the deviations observed upon the addition of identical volumes of pure DMSO. More pronounced chemical shift perturbations, however, were observed in the presence of compound 6, especially for residues 10 -19 and for many residues from Ile-31 to Ala-42. With the exception of the basic His-13, His-14, and Lys-16 residues, all other amino acid residues are A, shown is the interaction of compounds 6, 7, and 10 with monomeric A␤42. Shown is the average backbone amide proton and nitrogen chemical shift deviation obtained from two-dimensional 1 H, 15 N heteronuclear single quantum coherence spectra of 15 N-labeled A␤42 in the absence and presence of the compounds 6, 7, and 10. The compounds 6 and 10 were present at a compound/peptide ratio of 30:1, whereas the corresponding value for compound 7 was 24:1. Reference data were obtained after the addition of DMSO (without compounds) at the corresponding volume. B, shown is an illustration of the main interactions of compound 6 with hydrophobic amino acids of monomeric A␤42 using the NMR structure of A␤42 fibrils (51) consisting of five peptides (PDB entry 2BEG).
hydrophobic. Notably, these residues are located in the regions of the A␤42 peptide sequence that constitute the N-and C-terminal ␤-strands of A␤ fibrils (Fig. 9B) (51) .
The observed change of chemical shifts in dependence of the compound 6/A␤42 ratio was nearly linear, i.e. far from the saturation regime (supplemental Fig. S4 ). This indicated that the interaction between monomeric, NMR-observable A␤42 and compound 6 was weak with a K d in the mM range. The NMR STD technique is a method that allows the detection of interactions between small molecules and proteins in a wide range of affinities (K D ϳ 10 Ϫ8 -10 Ϫ3 M) (52) . In these experiments, an 1 H NMR signal from the peptide or protein was irradiated and kept saturated for a relatively long time. Then saturation transferred to all the other protons of the peptide as well as any ligand that was in contact with the peptide during the saturation period. A decrease in the 1 H NMR signal intensities of the ligand, constituting the STD signal, represented the binding event. The part of the small molecule that had the strongest contact/binding with A␤42 displays the most intense STD signal. For compound 6 the two peaks at ϳ5.8 and 6.0 ppm were well separated from the A␤42 peaks and selected for STD analysis (Fig. 10) . The two peaks belong to the protons directly attached to the pyrazole rings. After the addition of an A␤42 preparation enriched in oligomers, the peak at 5.8 ppm was already broadened in a conventional one-dimensional 1 H NMR spectrum, suggesting that the corresponding proton of compound 6 was involved in the interaction with A␤42 ( Fig. 10A, upper signals) . In line with its involvement in the interaction with A␤42, a clear STD signal was observed at both 5.8 and 6.0 ppm after irradiation at 0.6 ppm that saturates the methyl signals of A␤42 (Fig. 10A, lower  signals) . The aromatic protons from the 4-F-phenyl moieties (ϳ7.0 -7.7 ppm) were not separated from the A␤42 peaks but also showed clear STD signals after irradiation at 0.6 ppm.
Next we tested the impact of the irradiation frequency on the STD effect. When the irradiation frequency was moved to Ϫ1, Ϫ2, Ϫ3, and Ϫ5 ppm, a continuous decrease of the STD effect was observed (Fig. 10B ). Because no "visible" peptide signal is located at these up-field frequencies, the STD effects there should be caused by the "hidden" signals of the oligomeric peptide, which are broadened enough to be "NMR-invisible" but reach up to frequencies of Ϫ5 ppm due to severe line broadening. Therefore, the STD profile confirmed a binding event between compound 6 and A␤42 oligomers (Fig. 10B ). In line with a preferential interaction of compound 6 with A␤42 oligomers, the normally solubilized A␤42 preparation showed lower STD intensities (gray dots of Fig. 10B ). In addition, the normally solubilized A␤42 preparation that contains a smaller amount and potentially different types of oligomers did not show a STD effect at Ϫ5 ppm.
Rescue of A␤42-induced Toxicity and Prevention of A␤42-Uptake in Cultured Cells-To study the toxic effect of A␤42 on SH-SY5Y cells, we selected a crude A␤42 preparation containing mixtures of heterogeneous A␤42 oligomers and abundant monomers (20, 39) . This preparation was chosen to mimic the pathological situation in vivo where both monomeric and protofibrillar A␤ species populate the diseased AD brain. Furthermore, we reported that crude A␤42 preparations, when compared with purified monomers and protofibrils, were much more toxic to cultured cells including neurons and fibrillized extensively (20, 45) . Compounds 1, 5, 6, 7, and 10 were thus tested in a cell-based in vitro assay to determine their ability to increase the viability of SH-SY5Y cells treated with crude A␤42 as measured by a MTT reduction assay (20) . For this assay the ratio of compound to A␤42 was 1:1 (10 M) with a 1-h preincubation of the compound with crude A␤42 followed by a 24-h treatment of the cells (20) . The cell viability assay showed that compounds 5, 6, 7, and 10 but not compound 1 were able to reduce the toxicity of crude A␤42, resulting in increased cell viability (Fig. 11A) .
To better understand the underlying mechanism by which compounds 5, 6, 7, and 10 increased the cell viability of SH-SY5Y cells treated with crude A␤42, we developed an A␤42 uptake assay (Fig. 11B) . The assay is based on the fact that extracellular A␤42 aggregates have been shown to interact with cellular membranes followed by internalization by endocytosis resulting in the accumulation of intra-neuronal A␤42 (53) . For this assay the ratio of compound to A␤42 was 1:1 (3 M) with a 1-h preincubation of the compound with crude A␤42 followed by a 2-h treatment of the SH-SY5Y cells. Internalized A␤42 was determined using an ELISA for human A␤42. Compound 1 had little effect on crude A␤42 internalization (Ͻ10% reduction) when compared with conditions without compounds (defined as 0% reduction), whereas compounds 5, 6, 7, and 10 interfered with crude A␤42 internalization (ϳ30 -60% reduction). Thus, the improved cell viability of A␤42-treated SH-SY5Y cells observed in the presence of compounds 6, 7, and 10 correlated well with their capability to decrease the cellular uptake of crude A␤42 (Fig. 11C ).
DISCUSSION
The goal of this study was to rationally design small molecules capable of preventing the formation of toxic A␤42 species. In recent years a number of small molecule inhibitors of A␤42 aggregation have been studied. The majority of compounds, mainly natural products, contained phenolic moieties. Selected examples are apomorphine (18) , curcumin (25) , (Ϫ)epigallocatechine gallate (32, 33) , resveratrol (31), bi-and mono-flavonoids (54), tannic acid (34), nordihydroguaiaretic acid (34) , tolcapone (45) , RS-0466, RS-0406 (55) , and O4 (56) . Although all of these compounds have very different chemical structures, they share common features required for activity (25, 57) . These features are hydroxyl substituents on the aromatic moiety, a second terminal aromatic moiety, and a linker unit to which the aromatic moieties are attached. The optimal linker length appeared to be between 8 and 16 Å, and the linker should not contain more than two rotating bonds (25, 57) .
For our compounds we applied a rational design based on the 3-aminopyrazole moiety (35, 36) to retain entropically favorable multipoint hydrogen bond interactions with ␤-sheets (36) . The distance between donor and acceptor should be in the range of 3.5-4.0 Å, and the distance between acceptor and donor should be 2.6 -2.9 Å (35, 58) . In this respect, the Ampox compound (N 1 ,N 2 -bis(5-methyl-1H-pyrazol-3-yl)oxalamide; Refs. 35 and 36 and Fig. 1A) represented a suitable lead for compound optimization whereby the following criteria required to permeate biological membranes were targeted: molecular weight Յ 450, polar surface area Յ90 Å 2 , number of hydrogen-bond acceptors Յ 7, number of hydrogen-bond donors Յ 4, and lipophilicity (logarithm of n-octanyl alcohol/ water partition coefficient) Յ5 (59). Thus, we retained the 3-aminopyrazole ring, incorporated linker units with not more than two rotating bonds, and added aromatic moieties at each of the 3-aminopyrazole rings to enable -stacking and/or hydrophobic interactions with the residues of A␤42 (Fig. 1) .
The use of ThT-based screening assays (Fig. 2) allowed the rapid screening of our compounds and resulted in the identification of compounds 1, 2, 4, 8, 9, 11, 12 , and 14 with undesired structural features leading to inferior inhibition of A␤42 fibrillization, i.e. aromatic substituents at the 4-position of the 3-aminopyrazole ring and rigid-linkers. The data from different in vitro assays ( Fig. 3-10 ) suggested that the improved activity in inhibiting A␤42 fibrillization by compounds 3, 5, 6, 7, 10, and 13 was linked to their ability to adopt a conformation where additional -stacking and/or hydrophobic interactions with A␤42 were possible. The weak mM binding of compound 6 to monomeric A␤42 (supplemental Fig. S4 ) and the preference of compound 6 to bind to oligomeric A␤42 (Fig. 10B) suggested that the structurally related compounds 3, 5, 7, 10, and 13 bind preferably to oligomeric A␤42 species as well.
The preferred interaction of compound 6 with hydrophobic residues of the N-and C-terminal ␤-strands (Leu-17, Val-18, Phe-19, Ile-31, Ile-32, Val-36, Val-40, Ile-41, and Ala-42) of monomeric A␤42 (Fig. 9 ) can be directly linked to the presence of the 3-aminopyrazole ring and the attached aromatic substituents at the 5-position. The STD spectra (Fig. 10 ) showed that at all irradiation frequencies there is an energy transfer from A␤42 to compound 6 (Fig. 10A, lower signals) , clearly indicating that both the 3-aminopyrazole ring and the 4-F-phenyl substituent have direct binding contacts with these A␤42 residues. A similar mode of interaction was proposed earlier for the recognition of the hexapeptide sequence (KKLVFF) of residues 15-20 of A␤42 by a trimeric 3-aminopyrazole ligand (36) . FIGURE 11 . Inhibition of crude A␤42 induced toxicity and inhibition of internalization of crude A␤42 by compounds 1, 5, 6, 7, and 10 monitored with SH-SY5Y neuroblastoma cells. A, assessment of crude A␤42 toxicity in the presence of compounds 1, 5, 6, 7, and 10 by employing a MTT reduction assay is shown. Crude A␤42 was preincubated for 1 h with the compounds a 1:1 molar ratio (10 M) before the cells were treated with the mixture for 24 h. B, shown is an assessment of the efficacy of compounds 1, 5, 6, 7, and 10 to prevent crude A␤42 internalization into SH-SY5Y cells. Crude A␤42 was preincubated for 1 h with the compounds at a 1:1 molar ratio (3 M) before the cells were treated with the mixture for 2 h. C, shown is correlation between inhibition of internalization of crude A␤42 and inhibition of crude A␤42-induced toxicity by compounds 1, 5, 6, 7, and 10. The data are expressed as the mean Ϯ S.D. of three independent experiments.
The polyphenolic compound O4 preferably targets the hydrophobic residues 17-20 and 31-37 of A␤40 as well (56) . The importance of -stacking and/or hydrophobic interactions was also observed in the preferred binding of phthalocyanine tetrasulfate to the heptapeptide sequence (EGVLYVG) of residues 35-41 of ␣-synuclein (50) .
The suppression of the rise of the ThT-signal in kinetic experiments using A␤42 monomers ( Fig. 4A ) and A␤42 protofibrils ( Fig. 5A ) provide further evidence that compounds 5, 6, 7, and 10 interact with the ␤-sheets already present in oligomeric A␤42. Infrared spectroscopy and x-ray diffraction have demonstrated the presence of significant amounts of ␤-sheet structure in A␤42 protofibrils and fibrillar oligomers (60 -62) that appear as the earliest fibrillar aggregates within the A␤ amyloidogenic pathway (47) and are putatively a major cytotoxic A␤ species (63) . It was already demonstrated that ThT recognizes prefibrillar A␤ aggregates (64) and that the ThT fluorescence was only modestly increased (1.5-fold) when compared with fibrils (Ͼ100-fold). The lower ThT fluorescence of prefibrillar or oligomeric A␤ aggregates can be explained by the lower ␤-sheet content of oligomers (ϳ48 -57%) when compared with fibrils (61) .
Previous studies with small molecule inhibitors of A␤42 aggregation allowed the differentiation of active compounds into three subsets (34, 46) . Class I (e.g. Congo red, curcumin, nordihydroguaiaretic acid) inhibited A␤42 oligomerization but not A␤42 fibril formation. Class II (e.g. methylene blue, rhodamine B, phenol red) inhibited both A␤42 oligomerization and A␤42 fibril formation. Class III (e.g. orange G, piceid, tannic acid) inhibited A␤42 fibril formation but not A␤42 oligomerization (34, 46) . Regarding the fibrillization of A␤42 monomers and protofibrils, compounds 5, 6, 7, and 10 seemed to display the behavior of class III compounds and acted by kinetic stabilization of A␤42 oligomeric intermediates ( Figs. 4 and 5 ). In addition, compound 7 also increased the amount of soluble A␤42 aggregates similar to SDS sensitive A␤42 protofibrils (Fig.  5B ). Unlike class III compounds reported in literature (34) , compounds 5, 6, 7, and 10 were not able to disaggregate preformed A␤42 fibrils ( Fig. 6 ) into low molecular weight species. Again compound 7 displayed a somewhat different behavior by inducing the formation of A␤42 fibrils with reduced ThT binding capacity (Fig. 6D) .
FCS data revealed a reduction of the number of small A␤42 aggregates for compounds 5, 6, and 7 but not compound 10 (Fig. 7A) . The FCS data for larger A␤42 aggregates (Fig. 7B ) matched compound 6 when A␤42 monomers were used, leading to an increased amount of soluble A␤42 (Fig. 4B ). For compound 7, however, the use of A␤42 protofibrils resulted in the formation of A␤42 aggregates that were indistinguishable from SDS-sensitive A␤42 protofibrils (Fig. 5B ). Thus, we speculate that the A␤42 aggregates detected by FCS are different in size and conformation.
Compounds 6, 7, and 10 most efficiently increased the viability of cells treated with toxic A␤42 (Fig. 11A ) and decreased the cellular uptake of A␤42 (Fig. 11B) . NMR experiments showed an interaction between compound 6 and the two adjacent histidines at positions 13 and 14 of monomeric A␤42 (Fig.  9A ). Both residues are important for A␤42 cell membrane bind-ing and uptake (65). One possible mechanism for A␤42 oligomer toxicity is related to their interaction with lipid bilayers in which they might cause perturbation and/or permeabilization (18, 66) . An earlier study using human neuroblastoma cells showed that oligomeric A␤42 was internalized more efficiently than fibrillar A␤42 (67) . We speculate that a similar interaction of compounds 6, 7, and 10 with oligomeric A␤42 may in part explain their rescuing effect. Despite being a potent compound in the ThT IC 50 and kinetic of A␤42 monomer and protofibril fibrillization assays, compound 5 displayed a weaker rescuing capacity. This may be related to the relatively high degree of A␤42 internalization found in the presence of compound 5 (Fig. 11B ). This indicates that subtle differences between small molecule inhibitors of A␤42 fibrillization (electron-deficient 4-F-phenyl substituent for compound 6; electron-rich substituent (4-(CH 3 ) 2 N-phenyl for compound 7; electron-rich substituents 4-tolyl/2-thiophenyl for compound 10; electron-deficient 4-Cl-phenyl substituent for compound 5) can lead to different mechanistic interactions with A␤42 species, resulting in a different reduction of A␤42 mediated toxicity. A reduction of A␤42 toxicity in vitro was also observed for curcumin (68), (Ϫ)-epigallocatechine gallate (32) , resveratrol (69), RS-0406 (55, 70) , and O4 (56), which have different interactions with A␤42 as well. Furthermore, attenuation of A␤42 toxicity was also observed when the kinetic stabilization of A␤42 protofibrils was enhanced by adding A␤40 monomers (23) , and interestingly, small molecules stabilizing A␤42 protofibrils in vitro improved behavioral performance in APP-transgenic mice (71) .
In summary, compounds 6, 7, and 10 showed the validity of our inhibitor design (flexible (-CH 2 -CH 2 -) linker unit and aromatic substituents at the 5-position of 3-aminopyrazole) to target hydrophobic residues of A␤42. Compounds 6, 7, and 10 efficiently prevented pathological self-assembly of A␤42 monomers and A␤42 protofibrils by binding to oligomeric A␤42, broke down neurotoxic A␤42 oligomers, increased the viability of SH-SY5Y neuroblastoma cells when challenged with toxic crude A␤42 mixture, and decreased cellular uptake of A␤42. Thus, compounds 6, 7, and 10 have potential as novel drug candidates for the treatment of neurodegeneration in AD and related amyloid diseases.
